Table 1.
Baseline characteristics of the enrolled patients
| ID | Gender | CRT | H–H distance (km) | Cost analysis observation period (months pre‐ and post‐device) | Age (years) | BMI (kg/m2) | LVEF (%) | sPAP (mmHg) | BNP (pg/mL) | eGFR (mL/min) | EQ 5‐D |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | Yes | 70.1 | 56 (28 pre + 28 post) | 70 | 34.02 | 32 | 45 | 620 | 25.3 | 50 |
| 2 | F | No | 5.5 | 72 (36 pre + 36 post) | 78 | 25.64 | 23 | 45 | 271 | 27 | 60 |
| 3 | M | No | 2.2 | 10 (5 pre + 5 post) | 60 | 26.45 | 22 | 56 | 743 | 49.1 | 50 |
| 4 | F | No | 98.9 | 24 (12 pre + 12 post) | 84 | 25.78 | 55 | 35 | 473 | 45.6 | 60 |
| 5 | M | Yes | 14.7 | 44 (22 pre + 22 post) | 82 | 24.84 | 20 | 45 | 1531 | 52.8 | 55 |
| 6 | M | Yes | 278 | 36 (18 pre + 18 post) | 58 | 27.18 | 20 | 58 | 588 | 49.7 | 55 |
| 7 | M | No | 9.3 | 26 (13 pre + 13 post) | 51 | 33.63 | 33 | 32 | 278 | 113.4 | 80 |
BMI, body mass index; BNP, brain natriuretic peptide; CRT, cardiac resynchronization therapy; eGFR, estimated glomerular filtration rate; F, female; H–H, home–hospital; LVEF, left ventricular ejection fraction; M, male; sPAP, systolic pulmonary artery pressure.